 Connection
Philip Zeitler to Glucocorticoids
This is a "connection" page, showing publications Philip Zeitler has written about Glucocorticoids.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.637 |
|
|
|
-
Bowden SA, Connolly AM, Kinnett K, Zeitler PS. Management of Adrenal Insufficiency Risk After Long-term Systemic Glucocorticoid Therapy in Duchenne Muscular Dystrophy: Clinical Practice Recommendations. J Neuromuscul Dis. 2019; 6(1):31-41.
Score: 0.439
-
Ward LM, Weber DR, Wong SC, Apkon S, Clemens PR, Cripe LH, McMillan HJ, Mercuri E, Nasomyont N, Phung K, Renthal NE, Rutter MM, Tian C, Wood CL, Zeitler PS, Buccella F, Kinnett K, Furlong P. A Parent Project Muscular Dystrophy-sponsored International Workshop Report on Endocrine and Bone Issues in Patients with Duchenne Muscular Dystrophy: An Ever-changing Landscape. J Neuromuscul Dis. 2025 Jan-Feb; 12(1):22143602241303370.
Score: 0.166
-
Covar RA, Leung DY, McCormick D, Steelman J, Zeitler P, Spahn JD. Risk factors associated with glucocorticoid-induced adverse effects in children with severe asthma. J Allergy Clin Immunol. 2000 Oct; 106(4):651-9.
Score: 0.031
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|